Ultrasonographic and lipid changes in polycystic ovary syndrome according to hormonal treatment type;Cambios ultrasonográficos y en lípidos en el síndrome de ovario poliquístico de acuerdo al tipo de tratamiento

Ginecologia y Obstetricia de Mexico

Volumn 70, Issue JUN., 2002, Pages 285-288

  Carranza Lira, Sebastián ^a   Magaña Padilla, Norma Regina ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Chlormadinone; Combined hormonal contraceptive; Lipids; Polycystic ovary syndrome; Ultrasonography

Indexed keywords

CHLORMADINONE; DESOGESTREL PLUS ETHINYLESTRADIOL;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HORMONAL THERAPY; HUMAN; LIPID BLOOD LEVEL; OVARY FOLLICLE; OVARY POLYCYSTIC DISEASE; PATIENT ATTITUDE; RANDOMIZED CONTROLLED TRIAL; SEXUAL BEHAVIOR; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; CHLORMADINONE ACETATE; CHOLESTEROL; DESOGESTREL; DRUG THERAPY, COMBINATION; ESTRADIOL CONGENERS; ETHINYL ESTRADIOL; FEMALE; HUMANS; OVARIAN FOLLICLE; POLYCYSTIC OVARY SYNDROME; PROGESTERONE CONGENERS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 0036075587     PISSN: 03009041     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Endocrinología ginecológica e infertilidad
2. Polycystic ovary syndrome
3. Polycystic ovary syndrome aetiology and management
4. Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome
5. Role of progesterone in the development of luteinizing hormone and androgen abnormalities in polycystic ovary syndrome
6. Polycystic ovarian disease: Sonographic spectrum
7. Preoperative hormonal therapy of cystic adnexal masses
8. Pituitary function is altered during the same cycle in women with polycystic ovary syndrome treated with continuous or cyclic oral contraceptives or a gonadotropin-releasing hormone agonist
9. The relation of the gonadotrophin response to chlormadinone according to body weight in patients with amenorrhea due to polycystic ovarian syndrome
10. The influence of body weight on lipoprotein lipids in patients with polycystic ovary syndrome
11. Lipid metabolic studies in women with a polycystic ovary syndrome during treatment with a low-dose desogestrel-ethinylestradiol combination
12. Polycystic ovary syndrome and risk for myocardial infarction
13. Family study of hirsutism
14. A syndrome characterized by recurrent symptomatic functional ovarian cysts in young women
15. Group comparison of serum ethinyl estradiol, SHBG and CBG levels in 83 women using two low-dose combination oral contraceptives for three months
16. Effects of hormonal replacement on lipids and lipoproteins in postmenopausal women
17. Effects of estrogens on lipoprotein metabolism and cardiovascular disease in women
18. Response of plasma low density lipoprotein subfractions to oestrogen replacement therapy following surgical menopause
19. Metabolic effects of estrogens and progestins